Friday broker round-up UPDATE

AstraZeneca: Citi increases target price from 3000p to 3500p, while leaving its neutral rating unchanged.Burberry: Morgan Stanley ups target price from 1300p to 1400p and leaves its equal-weight rating unchanged.Genel Energy: Credit Suisse shifts target price from 1236p to 1246p keeping an outperform rating.GlaxoSmithKline: Deutsche Bank moves target price from 1930p to 1960p and maintains a buy recommendation.Halfords Group: UBS raises target price from 280p to 375p upgrading from sell to buy.MDM Engineering: Canaccord Genuity increases target price to 161p and reiterates a buy recommendation.National Grid: JP Morgan reduces target price from 785p to 735p and stays with its neutral rating.PayPoint: Panmure Gordon increases target price from 765p to 1000p and maintains a hold recommendation.Persimmon: UBS taked target price from 1175p to 1260p, but downgrades from buy to neutral.Reckitt Benckiser: UBS ups target price from 4730p to 5210p, reiterating its buy recommendation.Shire: Morgan Stanley raises target price from 2400p to 2625p, keeping an overweight rating.Signet Group: UBS moves target price from 4900p to 5000p and stays with its buy recommendation.Tate&Lyle: Citi takes target price rom 900p to 1000p reiterating a buy recommendation. UBS ups target price from 830p to 890p maintaing a neutral rating.Victrex: Numis ups target price from 1752p to 1775p, while its hold recommendation remains unchanged.Wolseley: HSBC Holdings ups target price from 1840p to 1860p and retains an underweight rating. Burberry Astrazeneca Tate & Lyle Victrex Halfords Genel Energy Glaxosmithkline Persimmon